pain, inflammation, nsaids and analgesics
DESCRIPTION
Pain, Inflammation, NSAIDs and Analgesics. BY DR KAUKAB AZIM. Learning Outcomes. By the end of the lecture the student should be able to Define and discuss the pathobiology of pain pathways - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/1.jpg)
Pain, Inflammation, NSAIDs and Analgesics
BY DR KAUKAB AZIM
![Page 2: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/2.jpg)
Learning OutcomesBy the end of the lecture the student should be able to
• Define and discuss the pathobiology of pain pathways• Explain the molecular mechanism of action common to all
nonsteroidal antiinflammatory drugs (NSAIDs)• Describe the pharmacological effects of each drug in each class.• Describe the pharmacokinetics of salicylates.• Describe the main adverse effects of the drugs of each class.• Describe the clinically important drug interactions of the drugs of each
class.• Describe the principal contraindications of the drugs of each class.• Describe the main therapeutic uses of NSAIDs and acetaminophen.
![Page 3: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/3.jpg)
What is inflammation?
• INFLAMMATION – is a reaction to tissue injury caused by the release of chemical mediators that cause both vascular response and the migration of fluids and cells to the injured site.
• It is a protective mechanism in which the body attempts to neutralize and destroy harmful agents at the site of tissue injury and establish condition for tissue repair.
![Page 4: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/4.jpg)
What is PainPain: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damageHyperaesthesia (hypersensitivity): Increased sensitivity to stimulation, excluding the special sensesHyperalgesia: Increased pain in response to a noxious stimulusAllodynia: Pain due to a stimulus that does not normally produce painFrom the International Association for the Study of Pain (IASP) definitions (Merskey, and Bogduk 1994)
![Page 5: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/5.jpg)
Physicians Have a Moral Obligation to Provide Comfort and Pain Management
Especially for those near the end of life!
• Pain is the most feared complication of illness• Pain is the second leading complaint in
physicians’ offices• Often under-diagnosed and under-treated• Effects on mood, functional status, and quality of
life• Associated with increased health service use
![Page 6: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/6.jpg)
18% of Elderly PersonsTake Analgesic Medications Regularly
(daily or more than 3 times a week)
• 71 % take prescription analgesics– 63% for more than 6 months
• 72% take OTC analgesics– Median duration more than 5 years
• 26% report side-effects– 10% were hospitalized– 41% take medications for side-effects
![Page 7: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/7.jpg)
Common Causes of Pain In Elderly Persons
• Osteoarthritis– back, knee, hip
• Night-time leg cramps• Claudication• Neuropathies
– idiopathic, traumatic, diabetic, herpetic• Cancer
![Page 8: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/8.jpg)
Pain Receptors
![Page 9: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/9.jpg)
Pain Intensity
Proportional to number of receptors stimulated
![Page 10: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/10.jpg)
Pain Pathway
![Page 11: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/11.jpg)
Pain Mechanism
Etiological Factorsinflammation/tissue damage/nerve lesions
Pain Sydromespost-operative/arthritic/back pain/neuropathic
![Page 12: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/12.jpg)
Mechanisms associated with peripheral sensitization to pain
![Page 13: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/13.jpg)
Nonsteroidal antiinflammatory drugs (NSAIDs)
Salicylic acid derivatives
Propionic acid derivatives
Acetic acid derivatives
Oxicams Indole derivatives
Selective COX-2 inhibitors
-Acetylsalicylic acid
-Sodiumsalicylate-Diflunisal-Mesalamine
IbuprofenKetoprofenNaproxen
DiclofenacKetorolac
PiroxicamMeloxicam
Indomethacin Celecoxib
Analgesic-antipyretic drug:Acetaminophen
![Page 14: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/14.jpg)
14
Prostaglandins as mediators
√
![Page 15: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/15.jpg)
–Non-selective (t NSAIDS) inhibit both isozymes.
–Side effects occur due to inhibition of COX-1(house keeping” enzyme)
•With selective COX-2 inhibitors (Coxibs), chances of GIT toxicity are less.•CVS side effects can occur
►
▼
![Page 16: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/16.jpg)
NSAIDS: Mechanism of action
• Main mechanism: Inhibition of COX
– Reversible (competitive) inhibitors– Irreversible inactivation (by Aspirin)
– Nonselective COX inhibitors (traditional NSAIDS)– Selective COX-2 inhibitors (Celecoxib)
![Page 17: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/17.jpg)
• Anti-inflammatory effect– reverses vasodilation, edema, tenderness
• Analgesic effect– By preventing PG mediated sensitization of nerve endings
• Antipyretic effect– Resets the hypothalamic thermostat by decreasing PG
synthesis– Vasodilation and heat loss– Do not cause hypothermia
NSAIDS: Effects
![Page 18: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/18.jpg)
• Antiplatelet aggregation effect
– Platelets have COX-1– Aspirin acetylates COX-1 to inhibit its activity in an
“irreversible manner”.– All other tNSAIDS- reversible inhibitors– Selective COX-2 inhibitors do not disturb platelet
aggregation at therapeutic doses– Acetaminophen do not inhibit platelet aggregation
![Page 19: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/19.jpg)
Common side effects of NSAIDS
• Gastrointestinal: Nonselective NSAIDS COX-1 inhibition
↓ gastroprotective PGs
– Gastric irritation, erosions, ulcers, gastric bleeding– Misoprostol (PGE1) can be used to prevent gastric
ulcers caused by tNSAIDS. – Selective COX-2 inhibitors are safer.
![Page 20: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/20.jpg)
• Renal: Sodium water retention, Papillary necrosis
• CVS: ↑ Na and water retention
• Platelet inhibition : bleeding– Selective COX-2 inhibitors and acetaminophen do not disturb
platelet function.
• CNS: Headache, confusion, seizures
• Hypersensitivity: “Pseudoallergic reaction” (due to increased leukotrienes)
![Page 21: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/21.jpg)
Salicylates
• Acetylated salicylate: Aspirin (Acetylsalicylic acid)
• Non-acetylated salicylates: sodium salicylate, diflunisal, mesalamine (5-ASA)
►Mechanism of action:– Aspirin: non-selective COX inhibitor; “Irreversible inhibition” by acetylation.
– Other salicylates: weak COX inhibitors; other mechanisms are involved.
![Page 22: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/22.jpg)
Dose dependent effects of Aspirin
Toxic levels
High Levels
![Page 23: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/23.jpg)
Effects of aspirin• Antiplatelet effect:
– Irreversible inactivation of COX-1 in platelets causes decreased production of TXA2 (aggregation promoter)
• Platelets (enucleated) cannot regenerate COX; effect lasts for 7-8 days.
– Irreversible inactivation of COX in endothelial cells causes decreased production of PGI2 (aggregation inhibitor)
• Endothelial cells can regenerate cyclooxygenase in a matter of hrs.
– Net effect is decreased platelet aggregation and increase in bleeding time.
– Low doses (80-160mg) are enough to inhibit aggregation without anti-inflammatory effects.
![Page 24: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/24.jpg)
24
COX-1
COX PG I2
Aggregation inhibitor
Aggregation promotor
Irreversible inhibition by Aspirin.
Enucleated platelets cannot regenerate COX.
Irreversible inhibition by Aspirin.
Nucleated endothelial cells can regenerate COX.
ANTIPLATELET EFFECT OF APIRIN
![Page 25: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/25.jpg)
• ↑ Plasma uric acid levels (at low dose)• ↓ Plasma uric acid levels (at high dose)
• Hyperventilation and compensated alkalosis (At high levels) – stimulates respiratory center, ↓ pCO2, Increased
bicarbonate in urine
• Metabolic acidosis: (At toxic levels)– Accumulation of salicylic acid due to zero order
kinetics at high levels.– Respiratory center depression; ↑ pCO2
![Page 26: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/26.jpg)
Salicylates: Adverse effects• Hypersensitivity reactions
– Pts with asthma, nasal polyps, chronic urticaria are more susceptible
– Pseudoallergic reaction– Cross reactivity with other NSAIDS
• Reye’s syndrome: Encephalopathy, hepatotoxicity.– Do not use aspirin in children with viral fever.
• Salicylism: Tinnitus, dimness of vision, mental confusion, sweating, hyperventilation, nausea and vomiting, diarrhea
![Page 27: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/27.jpg)
Salicylate intoxication– Tinnitus, Nausea and vomiting, abdominal cramps, gastric
bleeding.– Respiratory depression, Acidosis, generalized convulsions.– marked hyperthermia, dehydration.– Skin eruptions, petechial hemorrhages– coma and death (due to respiratory failure)
Treatment: Symptomatic and supportive. – External cooling and I.V. fluids with Na, K, and glucose.– Gastric lavage to remove unabsorbed drug– Forced alkaline diuresis to remove absorbed drug
![Page 28: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/28.jpg)
Salicylates: Therapeutic uses
• Keratolytic: salicylic acid• Counterirritant: Methylsalicylate• Antiinflammatory, analgesic, antipyretic
– Diflunisal: does not enter CNS; no antipyretic effect
Mesalamine (5-ASA):– inflammatory bowel diseases
Aspirin (Low doses):– MI, Angina– Atrial flutter/fibrillation– Transient ischemic attacks
![Page 29: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/29.jpg)
Other tNSAIDSIbuprofen, Naproxen:
– Widely used NSAID for pain and inflammation– GIT and CNS side effects are less
Diclofenec– Inhibits COX and lipooxygenase (to minor extent) – Decreases free radical production– Accumulates in synovial fluid
Ketorolac– Can be administered IV, IM– Used in postoperative pain
![Page 30: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/30.jpg)
Indomethacin• One of the most potent COX inhibitor
– Inhibits COX– Inhibits Phospholipase A2 – Reduces neutrophil migration– Reduces T and B cell proliferation
• Severe side effects (in 1/3rd pts)– Abdominal pain, diarrhea, GI bleeding– Frontal headache– Dizziness, confusion, depression, hallucinations
• Therapeutic Uses:– Arthritis (osteoarthritis, rheumatoid arthritis, Ankylosing
spondylitis, Gout)– Closure of ductus arteriosus
![Page 31: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/31.jpg)
Selective Cox-2 inhibitors“Coxibs”
• Celecoxib: first selective COX-2 inhibitor• Potent antiinflammatory, analgesic and antipyretic
activity• Incidence of GI bleeding and peptic ulcers is lower
than tNSAIDS• Does not inhibit platelet aggregation• Increased risk of cardiovascular side effects:
Hypertension, Thrombotic events
![Page 32: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/32.jpg)
Acetaminophen
• Analgesic and antipyretic agent– Inhibits COX-3 in CNS… ?
• Lacks significant anti-inflammatory and antiplatelet activity: very weak COX 1& 2 inhibitor
• Metabolized in the liver• Toxic doses deplete glutathione
– A metabolite, N-acetyl-p-benzoquinoneimine accumulates and causes hepatic necrosis.
– Acetylcysteine administered as antidote.
![Page 33: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/33.jpg)
Acetaminophen: MetabolismMINOR
PATHWAYP450 Enzyme
CYP2E1 and CYP1A2
MAJORPATHWAY
(Sulphate Conjugation)
MAJORPATHWAY
(Glucuronide conjugation)
RENAL EXCRETIONTOXIC METABOLITE
NAPQIN-acetyl-p-benzo-
quinone imine)
Toxic Doses (4gm+)Therapeutic Doses
GlutathioneAvailable
GlutathioneDepleted
RENAL EXCRETION Hepatic Necrosis
![Page 34: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/34.jpg)
Antiinflammatory agents:
Steroids
![Page 35: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/35.jpg)
Steroids Duration of action
Glucocorticoid activity
(antiinflammatory)
Mineralocorticoid activity
(Salt retaining)
Short actingHydrocortisone 8-12 1 1
Cortisone 8-12 0.8 0.8
Fludrocortisone 8-12 10 125Intermediate actingPrednisone 12-36 4 0.8
Prednisolone 12-36 4 0.8
Methylprednisolone 12-36 5 0.5
Triamcinolone 12-36 5 0Long actingBetamethasone 24-72 35 0Dexamethasone 24-72 30 0
![Page 36: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/36.jpg)
Glucocorticoids: Mechanism of action
![Page 37: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/37.jpg)
37
Steroids: Antiinflammatory effect
![Page 38: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/38.jpg)
Therapeutic uses
• Adrenal Uses• Non-adrenal uses:
– Inflammatory disorders• Asthma• Allergies: Allergic rhinitis, Acute allergic reactions• Autoimmune disorders: RA, SLE, glomerulonephritis
– Carcinomas– For immunosuppression
![Page 39: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/39.jpg)
Oral thrush (Candidiasis)
![Page 40: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/40.jpg)
Other Adverse effects of Glucocorticoids
• Cushing like syndrome• Psychosis• Peptic ulcers• Osteoporosis• Aseptic necrosis of hip• Easy bruisability, Purple striae on skin• Visceral fat deposition• Posterior subcapsular cataract, glaucoma• Hirsutism• Increased appetite• Growth retardation in children
![Page 41: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/41.jpg)
OPIOID ANALGESICS
![Page 42: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/42.jpg)
History of Opioids
• Opium is extracted from poppy seeds
• Used for thousands of years to produce:– Euphoria– Analgesia– Sedation– Relief from diarrhea– Cough suppression
![Page 43: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/43.jpg)
Mechanism of action
• Activation of peripheral nociceptive fibers causes release of substance P and other pain-signaling neurotransmitters from nerve terminals in the dorsal horn of the spinal cord
• Release of pain-signaling neurotransmitters is regulated by opioid agonists by acting presynaptically to inhibit substance P release, causing analgesia
![Page 44: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/44.jpg)
Molecular Effect of Opioid Receptor Activation
• Reduction or inhibition of neurotransmission, due largely to opioid-induced presynaptic inhibition of neurotransmitter release
• Involves changes in transmembrane ion conductance– Increase potassium conductance (hyperpolarization)– Inactivation of calcium channels
![Page 45: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/45.jpg)
Pharmacological Effects• Sedation and anxiolysis
– Drowsiness and lethargy– Apathy– Cognitive impairment
• Depression of respiration– Main cause of death from opioid overdose– Combination of opioids and alcohol is especially dangerous
• Cough suppression– Opioids suppress the “cough center” in the brain
• Pupillary constriction– pupillary constriction in the presence of analgesics is characteristic of
opioid use
![Page 46: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/46.jpg)
Pharmacological effects• Nausea and vomiting
– Stimulation of receptors in an area of the medulla called the chemoreceptor trigger zone causes nausea and vomiting
– Unpleasant side effect, but not life threatening• Gastrointestinal symptoms
– Opioids relieve diarrhea as a result of their direct actions on the intestines
• Other effects– Opioids can release histamines causing itching or more severe allergic
reactions including bronchoconstriction– Opioids can affect white blood cell function and immune function
![Page 47: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/47.jpg)
Three Opioid Receptors
• Mu
• Kappa
• Delta
![Page 48: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/48.jpg)
Delta Receptor
• It is unclear what delta’s responsible for.• Delta agonists show poor analgesia and little
addictive potential• May regulate mu receptor activity
![Page 49: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/49.jpg)
Mu-Receptor: Two Types
• Mu-1– Located outside spinal cord– Responsible for central interpretation of pain
• Mu-2– Located throughout CNS– Responsible for respiratory depression, spinal
analgesia, physical dependence, and euphoria
![Page 50: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/50.jpg)
Kappa Receptor
• Only modest analgesia• Little or no respiratory depression
• Little or no dependence • Dysphoric effects
![Page 51: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/51.jpg)
Mu and Kappa Receptor Activation
Response Mu-1 Mu-2 Kappa
Analgesia ✓ ✓ ✓Respiratory Depression ✓
Euphoria ✓Dysphoria ✓
Decrease GI motility ✓Physical
Dependence ✓
![Page 52: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/52.jpg)
AGONISTS
MorphineHeroin
HydromorphoneFentanylCodeine
![Page 53: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/53.jpg)
Morphine• PHARMACOKINETICS• Routes of administration (preferred) *Oral latency to onset –(15 – 60 minutes ) • * it is also sniffed, swallowed and injected. • * duration of action – ( 3 – 6 hours)• * First-pass metabolism results in poor • availability from oral dosing.• * 30% is plasma protein bound• EFFECTS AND MEDICAL USES• *symptomatic relief of moderate to severe pain• *relief of certain types of labored breathing• *suppression of severe cough (rarely)• *suppression of severe diarrhea • *AGONIST for mu, kappa, and delta receptors.
![Page 54: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/54.jpg)
Hydromorphone• PHARMACOKINETICS• *Routes of administration (Preferred)• *Oral• *latency to onset (15 – 30 minutes) • *Intravenous• *Duration of Action (3-4 hours)• *Peak effect (30-60 minutes)• PROPERTIES AND EFFECTS • * potent analgesic like morphine but is 7-10 • times as potent in this capacity.• *used fequently in surgical settings for moderate to • severe pain. (cancer, bone trauma, burns, renal colic.)
![Page 55: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/55.jpg)
Fentanyl• Pharmacokinetics• Routes of Administration * Oral, and transdermal (possibly intravenous) *Highly lipophilic *latency to onset (7-15 minutes oral; 12-17 hours transdermal *duration of action ( 1-2 hours oral; 72 transdermal) *80 – 85% plasma protein bound *90 % metabolized in the liver to inactive metabolites Other properties * 80 times the analgesic potency of morphine and 10 times the analgesic potency of hydromorphone. *high efficacy for mu 1 receptors. *most effective opiate analgesic
![Page 56: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/56.jpg)
Antagonists
NaloxoneNaltrexone
![Page 57: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/57.jpg)
Naltrexone• PHARMACOKINETICS• *latency to onset (oral tablet 15-30 min.)• *duration of action 24-72 hours• *peak effect (6-12 hours)• STRUCTURAL DISTINCTION• *Differs from naloxone insofar as the• allyl group on the nitrogen atom is supplanted • by a cyclopromethyl group.• EFFECTS• *Reverses the psychotomimetic effects of opiate • agonists.• * Reverses hypotension and cardiovascular instability• secondary to endogeneous endorphins (potent vasodilators)• *inhibits Mu, Delta, and Kappa receptors.
![Page 58: Pain, Inflammation, NSAIDs and Analgesics](https://reader036.vdocument.in/reader036/viewer/2022062400/56815d1e550346895dcb1a54/html5/thumbnails/58.jpg)
THANK YOU